Full Text
EE153 Cost-Effectiveness of First-Line Nivolumab Combination Therapy Vs Chemotherapy Alone for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Abstract

Authors

K. Ben-Umeh G. Okoye D.C. Malone J. King

Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×